ATE173925T1 - Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen - Google Patents

Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen

Info

Publication number
ATE173925T1
ATE173925T1 AT93923156T AT93923156T ATE173925T1 AT E173925 T1 ATE173925 T1 AT E173925T1 AT 93923156 T AT93923156 T AT 93923156T AT 93923156 T AT93923156 T AT 93923156T AT E173925 T1 ATE173925 T1 AT E173925T1
Authority
AT
Austria
Prior art keywords
calcium lactate
quinoloonecarbonic
irritative
administration
soluble calcium
Prior art date
Application number
AT93923156T
Other languages
English (en)
Inventor
Surendra C Mehta
Hua-Pin Huang
Galen W Radebaugh
Mahdi B Fawzi
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE173925T1 publication Critical patent/ATE173925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
AT93923156T 1992-10-27 1993-09-29 Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen ATE173925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/966,998 US5290794A (en) 1992-10-27 1992-10-27 Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms

Publications (1)

Publication Number Publication Date
ATE173925T1 true ATE173925T1 (de) 1998-12-15

Family

ID=25512170

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923156T ATE173925T1 (de) 1992-10-27 1993-09-29 Lösliche calciumlaktat/chinoloncarbonsäuren komplexe als nichtreizende parenterale verabreichungsformen

Country Status (13)

Country Link
US (1) US5290794A (de)
EP (1) EP0666743B1 (de)
JP (1) JPH08504190A (de)
AT (1) ATE173925T1 (de)
AU (1) AU670838B2 (de)
CA (1) CA2144652A1 (de)
DE (1) DE69322405T2 (de)
DK (1) DK0666743T3 (de)
ES (1) ES2124797T3 (de)
MX (1) MX9306321A (de)
NZ (1) NZ256962A (de)
SG (1) SG46482A1 (de)
WO (1) WO1994009779A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5602254A (en) * 1995-05-26 1997-02-11 Warner-Lambert Company Method for making quinoline carboxylic acids or naphthyridine carboxylic acids in free base form
ID21415A (id) 1997-12-05 1999-06-10 Upjohn Co Senyawa-senyawa antibiotik magnesium quinolon
TW200612941A (en) * 2004-07-02 2006-05-01 Daiichi Seiyaku Co Quinorone-containing pharmaceutical composition
US7919504B2 (en) * 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3508816A1 (de) * 1985-01-10 1986-07-10 Bayer Ag, 5090 Leverkusen 6,7-disubstituierte 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphtyridin-3-carbonsaeuren
US4771054A (en) * 1985-01-23 1988-09-13 Warner-Lambert Company Antibacterial agents
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US4851418A (en) * 1987-08-21 1989-07-25 Warner-Lambert Company Naphthyridine antibacterial agents containing an α-amino acid in the side chain of the 7-substituent
US4929613A (en) * 1987-08-26 1990-05-29 Warner-Lambert Company Antibacterial agents
DE3831514A1 (de) * 1988-09-16 1990-03-22 Bayer Ag Ph-neutrale waessrige loesungen von chinoloncarbonsaeuren
US5057520A (en) * 1989-03-24 1991-10-15 Abbott Laboratories 7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
US4916141A (en) * 1989-03-28 1990-04-10 Warner-Lambert Company (S)-7-(3-amino-1-pyrrolidinyl)-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid
NZ232740A (en) * 1989-04-20 1992-06-25 Riker Laboratories Inc Solution for parenteral administration comprising a 1h-imidazo(4,5-c) quinolin-4-amine derivative, an acid and a tonicity adjuster
JPH085779B2 (ja) * 1989-09-22 1996-01-24 杏林製薬株式会社 フレロキサシン点眼液
EP0425443A1 (de) * 1989-10-27 1991-05-02 Ciba-Geigy Ag Injizierbares parasitizides Mittel
DK0507851T3 (da) * 1989-12-29 1997-08-25 Abbott Lab Quinoloncarboxylsyre-matalion-syrekomplekser

Also Published As

Publication number Publication date
MX9306321A (es) 1994-04-29
NZ256962A (en) 1996-08-27
CA2144652A1 (en) 1994-05-11
EP0666743B1 (de) 1998-12-02
DK0666743T3 (da) 1999-08-16
DE69322405T2 (de) 1999-04-29
ES2124797T3 (es) 1999-02-16
JPH08504190A (ja) 1996-05-07
US5290794A (en) 1994-03-01
DE69322405D1 (de) 1999-01-14
AU5293793A (en) 1994-05-24
SG46482A1 (en) 1998-02-20
EP0666743A1 (de) 1995-08-16
AU670838B2 (en) 1996-08-01
WO1994009779A1 (en) 1994-05-11

Similar Documents

Publication Publication Date Title
DE69129861D1 (de) Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
NZ334124A (en) Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
IS4146A (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
DE59102210D1 (de) Galanthemin enthaltende pharmazeutische Formulierung zur Behandlung des Alkoholismus.
MY117109A (en) Injectable quinolone formulations.
IL96776A (en) Antibacterial compositions containing quinolone carboxylic acid-metal ion-acid complexes
ES2078567T3 (es) Preparados farmaceuticos y utilizacion de los oligo-sacaridos para la elaboracion de dichos preparados.
NO20000446L (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser
DK0412554T3 (da) Sustained-release-præparat til administration i hjernen
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
ATE356637T1 (de) Supramolekulare komplexe enthaltende arzneimittel
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
EP0799618A3 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
FR2794976B1 (fr) Compositions pharmaceutiques a action cicatrisante ou anti-complementaire comprenant un derive de dextrane
DK0666743T3 (da) Opløselige calciumlactat/quindoncarboxylsyrer-komplekser som ikke-irriterende parenterale former
RU96104062A (ru) Средство "витадерм" в комплексной терапии ожоговых ран
WO1992007564A3 (en) Method of treating demyelinating disease
EP0621789A4 (en) Pharmaceutical pentapeptide compositions and methods of use thereof.
UA12937A (uk) Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
MX9706759A (es) Uso de penciclovir para el tratamiento de virus deherpes 8 humano.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee